Exploration
Accueil
Racine
Exploration
Accueil
Racine

Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Finlande occidentale And NotMerja Haaparanta

List of bibliographic references

Number of relevant bibliographic references: 26.
Ident.Authors (with country if any)Title
000D49 Juho Joutsa [Finlande] ; Kirsti Martikainen ; Solja Niemel ; Jarkko Johansson ; Sarita Forsback ; Juha O. Rinne ; Valtteri KaasinenIncreased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders.
001088 Juho Joutsa [Finlande] ; Kirsti Martikainen [Finlande] ; Solja Niemel [Finlande] ; Jarkko Johansson [Finlande] ; Sarita Forsback [Finlande] ; Juha O. Rinne [Finlande] ; Valtteri Kaasinen [Finlande]Increased Medial Orbitofrontal [18 F]fluorodopa Uptake in Parkinsonian Impulse Control Disorders
001907 Maja Kojovic [Royaume-Uni] ; Mikko Kuoppam Ki [Finlande] ; Niall Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]“Progressive delayed‐onset postanoxic dystonia” diagnosed with PANK2 mutations 26 years after onset—An update
001A23 M. K. Karvonen [Finlande] ; V. Kaasinen [Finlande] ; M. Korja [Finlande] ; R. J. Marttila [Finlande]Ropinirole diminishes myoclonus and improves writing and postural balance in an ULD patient
002481 Anna Brück [Finlande] ; Sargo Aalto [Finlande] ; Elina Rauhala [Finlande] ; Jörgen Bergman [Finlande] ; Reijo Marttila [Finlande] ; Juha O. Rinne [Finlande]A follow‐up study on 6‐[18F]fluoro‐L‐dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen
002822 Aki S. Havulinna [Finlande] ; Pentti J. Tienari [Finlande] ; Reijo J. Marttila [Finlande] ; Kirsti K. Martikainen [Finlande] ; Johan G. Eriksson [Finlande] ; Olli Taskinen [Finlande] ; Elena Moltchanova [Finlande] ; Marjatta Karvonen [Finlande]Geographical variation of medicated parkinsonism in Finland during 1995 to 2000
002E27 Juliane Winkelmann [Allemagne] ; Oli Polo [Finlande] ; Federica Provini [Italie] ; Sonja Nevsimalova [République tchèque] ; David Kemlink [République tchèque] ; Karel Sonka [République tchèque] ; Birgit Högl [Autriche] ; Werner Poewe [Autriche] ; Karin Stiasny-Kolster [Allemagne] ; Wolfgang Oertel [Allemagne] ; Al De Weerd [Pays-Bas] ; Luigi Ferini Strambi [Italie] ; Marco Zucconi [Italie] ; Peter P. Pramstaller [Italie] ; Isabelle Arnulf [France] ; Claudia Trenkwalder [Allemagne] ; Christine Klein [Allemagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Svenja Happe [Allemagne] ; David Rye [États-Unis] ; Pasquale Montagna [Italie]Genetics of restless legs syndrome (RLS): State‐of‐the‐art and future directions
002E95 Chul Hyoung Lyoo [Corée du Sud] ; Sargo Aalto [Finlande] ; Juha O. Rinne [Finlande] ; Ki Ook Lee [Corée du Sud] ; Seung Hun Oh [Corée du Sud] ; Jin Woo Chang [Corée du Sud] ; Myung Sik Lee [Corée du Sud]Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait
003098 CHUL HYOUNG LYOO [Corée du Sud] ; Sargo Aalto [Finlande] ; Juha O. Rinne [Finlande] ; KI OOK LEE [Corée du Sud] ; SEUNG HUN OH [Corée du Sud] ; JIN WOO CHANG [Corée du Sud] ; MYUNG SIK LEE [Corée du Sud]Different Cerebral Cortical Areas Influence the Effect of Subthalamic Nucleus Stimulation on Parkinsonian Motor Deficits and Freezing of Gait
003175 Anna Brück [Finlande] ; Sargo Aalto [Finlande] ; Elina Nurmi [Finlande] ; Tero Vahlberg [Finlande] ; Jörgen Bergman [Finlande] ; Juha O. Rinne [Finlande]Striatal subregional 6‐[18F]fluoro‐L‐dopa uptake in early Parkinson's disease: A two‐year follow‐up study
003293 Kirsti K. Martikainen [Finlande] ; Tiina H. Luukkaala [Finlande] ; Reijo J. Marttila [Finlande]Parkinson's disease and working capacity
003626 Anna Brück [Finlande] ; Sargo Aalto [Finlande] ; Elina Nurmi [Finlande] ; Tero Vahlberg [Finlande] ; Jorgen Bergman [Finlande] ; Juha O. Rinne [Finlande]Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease : A two-year follow-up study
003C79 Valtteri Kaasinen [Finlande] ; Sargo Aalto [Finlande] ; Kjell N Gren [Finlande] ; Juha O. Rinne [Finlande]Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease
003F77 Katinka Tuisku [Finlande] ; Matti Mikael Holi [Finlande] ; Kristian Wahlbeck [Finlande] ; Aulikki Johanna Ahlgren [Finlande] ; Hannu Lauerma [Finlande]Quantitative rest activity in ambulatory monitoring as a physiological marker of restless legs syndrome: A controlled study
004085 Juha-Matti Savola [Finlande] ; Michael Hill [Royaume-Uni] ; Mia Engstrom [Finlande] ; Hannele Merivuori [Finlande] ; Siegfried Wurster [Finlande] ; Steven G. Mcguire [Royaume-Uni] ; Susan H. Fox [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada]Fipamezole (JP‐1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson's disease
004939 Anne-Maria Kuopio [Finlande] ; Reijo J. Marttila [Finlande] ; Hans Helenius [Finlande] ; Miikka Toivonen [Finlande] ; Urpo K. Rinne [Finlande]The quality of life in Parkinson's disease
004D53 Anne-Maria Kuopio [Finlande] ; Reijo J. Marttila [Finlande] ; Hans Helenius [Finlande] ; Urpo K. Rinne [Finlande]Environmental risk factors in Parkinson's disease
005D54 Rinne [Finlande] ; A. Laihinen [Finlande] ; U. K. Rinne [Finlande] ; K. N Gren [Finlande] ; J. Bergman [Finlande] ; U. Ruotsalainen [Finlande]PET study on striatal dopamine D2 receptor changes during the progression of early parkinson's disease
005D60 Rinne [Finlande]Nigral degeneration in parkinson's disease
005E67 J. O. Rinne [Finlande] ; A. Laihinen [Finlande] ; U. K. Rinne [Finlande] ; K. Nagren ; J. Bergman ; U. RuotsalainenPET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease
005E70 J. O. Rinne [Finlande]Nigral degeneration in Parkinson's disease
006025 Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse]Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease
006286 Rinne [Finlande] ; A. Laihinen [Finlande] ; J. O. Rinne [Finlande] ; K. Na Gren [Finlande] ; J. Bergman [Finlande] ; U. Ruotsalainen [Finlande]Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease
006409 U K Rinne [Finlande]Early dopamine agonist therapy in Parkinson's disease.
006461 Rinne [Finlande]Early dopamine agonist therapy in Parkinson's disease
006688 Calne [Canada] ; Urpo K. Rinne [Finlande]Controversies in the management of Parkinson's disease
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024